JEJoshy Maducolil Easow

Joshy Maducolil Easow

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joshy Maducolil Easow has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Interferon Inducible Guanylate Binding Protein 5 (GBP5) and Its Association With Oxidative Stress Markers in Regulating Dengue Severity: A Clinical and In Vitro Evaluation

    by Sanchita Chakraborty, Anand Kasirajan, Anupama Sunil, Aman Kumar Mohanty, Siva Ranganathan Green, Joshy M. Easow, Agiesh Kumar Balakrishna Pillai

    Human guanylate‐binding proteins (GBPs), induced by interferon in endothelial cells, are being explored as therapeutic targets for viral and metabolic diseases. However, their role in dengue pathogenesis, particularly regarding endothelial leakage in severe cases, remains unclear. To shed some light, the current study assessed mRNA and plasma GBP5 levels in 26 patients with severe dengue (SD), 15 with warning signs (DWW), 15 without warning signs (DWOW), and 10 healthy controls, using RT‐PCR and ELISA, respectively. Correlation between plasma GBP5 levels and oxidative stress markers, such as plasma lipid peroxidation, Protein oxidation, and DNA oxidation, was further investigated. GBP5 knockdown was assessed for its effects on oxidative stress and endothelial integrity in the HUVEC model. During the early febrile phase, GBP5 level was significantly elevated in all dengue cases compared to HC; towards the critical phase, there was a sharp decline observed in SD ( p < 0.001) and DWW ( p < 0.05) cases, which is accompanied by an increased oxidative stress marker, indicating its plausible association with dengue severity. Interferon stimulation of HUVEC cells significantly increased GBP5 expression ( p < 0.05) and sustained oxidative stress levels, while GBP5 silencing raised oxidative stress and lowered endothelial integrity. Our findings highlight the potential of GBP5 as a prognostic marker and therapeutic target in the management of dengue.


  • Open Access

    Non-dermatophytic Onychomycosis: The Etiological Agents and their Antifungal Susceptibility Response to Plain Ciclopirox Versus Ciclopirox Coated on Silver Nanoparticles – An In vitro Study

    by Y. Valentina, Joshy M. Easow

    Onychomycosis is a fungal infection of the fingernails or toenails caused by fungi. Ciclopirox nail lacquer is generally used for the treatment of patients with onychomycosis, but the duration of treatment is long and indefinite. Hence, Silver nanoparticles were coated with 8% Ciclopirox, and In vitro antifungal susceptibility was done to check its effectiveness over plain 8% Ciclopirox. This Analytical study included a total of 100 nail-clipping/Nail scrapping specimens from patients attending DVL OPD, MGMCRI, with suspected Onychomycosis for a period of one year. The sample was subjected to microscopy and culture identification of the pathogen. In vitro Antifungal susceptibility testing was performed against plain 8% Ciclopirox and 8% Ciclopirox coated on silver Nanoparticles by broth dilution method as per CLSI M38-A. The overall prevalence of Onychomycosis was 39%, caused by 6% of dermatophytes and 33% of non-dermatophytes. The incidence was 65% in toe nail and 35% in fingernail. The female is more predominant than male. Distal and lateral onychomycosis are the commonest clinical types. Aspergillus niger (13%) was the etiologic agent of onychomycosis due to NDOM. The MICs with 8% Ciclopirox coated on silver nanoparticles ranged from 0.4-0.7 μg/ml and the rate of growth inhibition was better when compared to plain 8% Ciclopirox MICs which ranged from 0.5-0.8 μg/ml. The study concludes that A. niger is the agent of NDOM and our findings hold implications of Onychomycosis for both the clinicians and researchers, to improve the clinical outcomes of the patients.

  • Open Access

    MIC breakpoints of XDR Enterobacterales Towards Polymyxin B, Colistin, and Tigecycline - Clinical Insights and Therapeutic Outcomes from A Descriptive Study

    by R. Kalaivani, Arunava Kali, Joshy M. Easow

    The prevalence of antibiotic resistance among Gram-negative bacteria, particularly Enterobacterales, is rising. Extensively drug-resistant (XDR) Enterobacterales demonstrate nonsusceptibility to all except two or fewer classes of antibiotics, where it retains susceptibility to at least one agent. Besides tigecycline, colistin and polymyxin B are often the only available therapeutic options in developing countries. The aim of this study was to determine the susceptibility of XDR Enterobacterales to colistin, polymyxin B, and tigecycline by determining the MIC using microbroth dilution and analyzing the treatment outcome. A descriptive study was done at Mahatma Gandhi Medical College and Research Institute, Pondicherry, from May 2023 to July 2023. The study included non-ICU patients aged 18 years or older, who had infections caused by XDR Enterobacterales isolated from clinical specimens during the study period and provided informed consent. All quantitative measurement values in this study were analyzed using descriptive statistical methods. Colistin and polymyxin B MIC of 109 clinical isolates of XDR Enterobacterales were tested by microbroth dilution. Tigecycline MIC was determined for 73 of these isolates. Forty-eight patients received colistin or polymyxin B monotherapy and their treatment outcomes were documented. Out of the 109 XDR isolates, 16 (14.7%) were resistant to colistin, while 11 (10.1%) were resistant to polymyxin B. Tigecycline MIC values ranged from 0.06 µg/mL to 4 µg/mL. Successful treatment outcome was observed in 23.5% of patients with colistin and/or polymyxin B resistant isolates, whereas it was 70.9% in patients with colistin and polymyxin B intermediate isolates. The present study revealed that K. pneumoniae emerged as the predominant isolate among XDR Enterobacterales in our healthcare facility. Although only a small proportion of strains exhibited resistance to polymyxin B, colistin, and tigecycline, the treatment outcomes were notably poor in the case of colistin and/or polymyxin B resistant strains, underscoring the grave therapeutic limitations posed by these resistant pathogens.

  • Open Access

    Categorization of Hepatitis B Infected Patients Attending a Tertiary Care Centre, Puducherry

    by Sangeetha Munuswamy, S. Umadevi, Kalaivani Ramakrishnan, Joshy M. Easow

    Hepatitis B infection is a common disease worldwide. Hepatitis B is one of the leading cause of malignancy and cirrhosis of liver. The diagnosis of Hepatitis B Virus (HBV) infection is mainly made through detection of serological markers. Our study aimed to detect presence of Hepatitis B Precore Antigen (HBeAg) and Antibodies to Hepatitis B core Antigen (HBcAg) among Hepatitis B Surface Antigen (HBsAg) positive samples detected in Microbiology laboratory during the study period. HBeAg, Total Anti HBc and Anti HBcIgM was detected using ELISA (DIA.PRO – ITALY) and patients were categorized based on presence of HBeAg, Total Anti HBc and Anti HBcIgM. Out of 180 samples tested positive for HBsAg, majority belonged to the age group of 41-60 years. With regard to gender, males were found to be majority and four percent were antenatal women. HBeAg was found in 20.6% patients indicating high infectivity. Out of 180 samples, 9.45% were found to have acute infection and 90.55% were with chronic infection. Among the patients with acute infection, 58.8% had high infectivity whereas in patients with chronic infection 16.56% had high infectivity. HBV Screening and categorization of positive patients are important to prevent chronic hepatitis, its complications among infected patients and to reduce the transmission of HBV in the community.

  • Open Access

    Case Series of Melioidosis in a Tertiary Health Care Centre in Puducherry, India

    by Joshy M. Easow, Namrata K. Bhosale, S. Pramodhini, Ramya Priyadarshini

    Melioidosis, a potentially fatal disease caused by the bacterium Burkholderia pseudomallei continues to be neglected in the Indian Subcontinent despite bearing about 44% of the global burden. Diagnosis poses a significant challenge since the disease presents a wide range of symptoms and closely mimics tuberculosis and pneumonia both of which are endemic in India. Sophisticated diagnosis and treatment often become unaffordable for patients from rural or low-income backgrounds. We present five cases of melioidosis from a tertiary care hospital (Mahatma Gandhi Medical College and Research Institute ) in Pondicherry that exhibited predominantly high-grade fever, abdominal pain, and vomiting. Radiological imaging revealed abnormalities in the brain (1/5, 20%), lung (3/5, 60%), liver (2/5, 40%), spleen (2/5, 40%), kidney (2/5, 40%), and prostate gland (1/5, 20%). Burkholderia pseudomallei infection was confirmed through blood culture. Treatment with meropenem or ceftazidime was initiated immediately. Neuromelioidosis was confirmed in one patient. The clinical diagnoses for the remaining cases were as follows: septic shock, melioidosis with urosepsis, and refractory shock. Three patients required intensive care and of the five, one patient was discharged, one died, and three discontinued treatments against medical advice. In the case of the deceased patient, the clinical diagnosis encompassed refractory shock accompanied by lactic acidosis, melioidosis, and community-acquired pneumonia, which subsequently progressed to acute respiratory distress syndrome (ARDS). Notably, this patient presented with co-morbidities, notably type 2 diabetes mellitus. This exemplifies the difficulty faced by patients from low-income backgrounds which forces them to discontinue expensive treatment. The true burden of melioidosis in the Indian Subcontinent is uncertain as many cases remain undiagnosed. Unawareness of the disease, low index of suspicion among medical professionals, incorrect treatment, and discontinuation contribute to the disease burden. It is therefore imperative that melioidosis is brought to the attention of healthcare policymakers to determine the true burden of the disease by prioritizing nationwide surveillance and diagnosis.


  • Open Access

    Analyzing Breakthrough Infections in a Tertiary Care Hospital: A Retrospective Study Utilizing RAT-Based Screening

    by K. Vanathy, Raji Ramachandran Pillai, Malarvizhi Ramalingam, Agiesh Kumar Balakrishna Pillai, G. Ezhumalai, Joshy Maducolil Easow

  • Open Access

    Ochrobactrum intermedium septicemia

    by Pramodhini Subramanian, Namrata K Bhosale, Joshy M Easow, Chandni Chandramouli, K S Chenthil

    Ochrobactrum species are emerging Gram-negative, non-fermenting bacteria with low virulence. Infection with the Ochrobactrum species is commonly nosocomial and has been reported in patients with indwelling medical devices and implants. Among the species of Ochrobactrum infecting humans, Ochrobactrum anthropic and Ochrobactrum intermedium are the commonest ones. We present a case of septicemia caused by Ochrobactrum intermedium in a 75-year-old patient with lower limb cellulitis. This report describes the epidemiology, clinical manifestations, laboratory diagnosis, antibiotic susceptibility pattern, and treatment of Ochrobactrum infections.


  • Open Access

    Ventilator-associated pneumonia

    by Marie Victor Pravin Charles, Arunava Kali, Joshy M Easow, Noyal M Joseph, Murugesan Ravishankar, Srirangaraj Srinivasan, Shailesh Kumar, Sivaraman Umadevi


  • Open Access

    Anterior abdominal wall abscess caused by Streptococcus pneumoniae in a patient with self-inflicted stab injury: An unusual presentation

    by Shailesh Kumar, Sivaraman Umadevi, Joshy Maducolil Easow, Noyal Mariya Joseph, Sreenivasan Srirangaraj, Kandha Kumari, Selvaraj Stephen

    Streptococcus pneumoniae is a major cause of community-acquired pneumonia, otitis media, paranasal sinusitis, bacteremia and meningitis, as well as osteomyelitis and occasionally peritonitis. We report the case of a 25-year-old female who had stabbed herself with a kitchen knife above the umbilicus 10 days prior to admission. Subsequently, she developed an anterior abdominal wall abscess caused by S. pneumoniae. This case is unusual as the focus was distant from the respiratory tract, the usual primary site of infection caused by this organism. Furthermore, the case assumes significance because it occurred in the absence of any typical risk factors for S. pneumoniae.